Selective inhibition of Fcepsilon RI-mediated mast cell activation by a truncated variant of Cbl-b related to the rat model of type 1 diabetes mellitus.
about
E3 ubiquitin ligase Cbl-b in innate and adaptive immunity.Lipid raft-regulated IGF-1R activation antagonizes TRAIL-induced apoptosis in gastric cancer cells.Oxaliplatin enhances TRAIL-induced apoptosis in gastric cancer cells by CBL-regulated death receptor redistribution in lipid rafts.C-Cbl reverses HER2-mediated tamoxifen resistance in human breast cancer cells.
P2860
Selective inhibition of Fcepsilon RI-mediated mast cell activation by a truncated variant of Cbl-b related to the rat model of type 1 diabetes mellitus.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Selective inhibition of Fcepsi ...... l of type 1 diabetes mellitus.
@en
Selective inhibition of Fcepsi ...... l of type 1 diabetes mellitus.
@nl
type
label
Selective inhibition of Fcepsi ...... l of type 1 diabetes mellitus.
@en
Selective inhibition of Fcepsi ...... l of type 1 diabetes mellitus.
@nl
prefLabel
Selective inhibition of Fcepsi ...... l of type 1 diabetes mellitus.
@en
Selective inhibition of Fcepsi ...... l of type 1 diabetes mellitus.
@nl
P2093
P2860
P356
P1476
Selective inhibition of Fcepsi ...... l of type 1 diabetes mellitus.
@en
P2093
Hirohei Yamamura
Mami Okazaki
Naoko Hori-Tamura
S M Shahjahan Miah
Tomoko Hatani
Xiujuan Qu
P2860
P304
P356
10.1093/JB/MVI088
P50
P577
2005-06-01T00:00:00Z